SOITEC : SOITEC ANNOUNCES END OF PATENT LAWSUIT WITH SIGEN
Mar 29, 2017 17:50 pm UTC| Business
SOITEC ANNOUNCES END OF PATENT LAWSUIT WITH SIGEN Bernin (Grenoble), France, March 29, 2017- Soitec, a world leader in designing and manufacturing semiconductor materials for the electronics industry, and Silicon...
Arduino Day 2017 -- Bringing Makers and Developers Together on April 1st
Mar 29, 2017 17:42 pm UTC| Business
San Jose, CA, March 29, 2017 -- Arduino, the world’s leading open source hardware and software platform, will celebrate its fourth annual Arduino Day, giving developers around the world a unique opportunity to come...
Kanguru Rolls Out Great New Features for Administrators Remotely Managing Encrypted USB
Mar 29, 2017 17:42 pm UTC| Business
MILLIS, Mass., March 29, 2017 -- The Kanguru Remote Management Console™ (KRMC™) is an exceptional solution for administrators of all types of security-conscious organizations to manage and protect sensitive data on...
Heritage Oaks Bancorp Announces Results of Special Meeting of Shareholders
Mar 29, 2017 17:40 pm UTC| Business
PASO ROBLES, Calif., March 29, 2017 -- Heritage Oaks Bancorp (the "Company") (Nasdaq:HEOP), a bank holding company and the parent of Heritage Oaks Bank (“Bank”), announced today that at the Company's special meeting of...
Corporate Capital Trust to Hold Earnings Call on April 6, 2017
Mar 29, 2017 17:35 pm UTC| Business
Orlando, Fla., March 29, 2017 -- Corporate Capital Trust, a business development company that provides individuals the opportunity to invest in the debt of privately owned American companies, will hold an earnings...
Health Data Vision’s MRCS 4.25 Release Makes Improvements for its Self-Service Users
Mar 29, 2017 17:12 pm UTC| Business
BURBANK, Calif., March 29, 2017 -- Health Data Vision, Inc. (HDVI), a leader in the medical record retrieval and review (MRR) industry, today announced the release of Medical Record Collection System (MRCS) 4.25, which...
Mar 29, 2017 17:09 pm UTC| Business
Paris, 29 March 2017, 7pm AB Science announces that masitinib study in primary and secondary progressive forms of multiple sclerosis has passed its non-futility test at 2 years The study has completed patient...